Exscientia Plc (EXAI) Financials

EXAI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 671.0 million 191.7 million
2023-06-30 711.9 million 185.2 million
2023-03-31 747.5 million 192.7 million
2022-12-31 949.5 million 249.7 million

EXAI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -46.6 million 7.8 million
2023-06-30 -60.4 million 8.6 million
2023-03-31 -69.6 million 8.6 million
2022-12-31 -80.8 million 12.6 million

EXAI Net Income

No data available :(

EXAI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 447.2 million - 21.9 million
2023-06-30 505.2 million - 23.3 million
2023-03-31 554.3 million - 23.8 million
2022-12-31 739.3 million - 19.9 million

EXAI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 151.9 million
2023-06-30 156.2 million
2023-03-31 152.7 million
2022-12-31 150.3 million

EXAI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4.9 million 38.7 million 13.6 million -
2023-06-30 8.3 million 39.8 million 14.7 million -
2023-03-31 15.8 million 41.4 million 13.5 million -
2022-12-31 10.4 million 52.0 million 12.0 million -

EXAI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 10.8 million 8.2 million
2023-06-30 3.8 million 7.9 million
2023-03-31 7.1 million 10.5 million
2022-12-31 9.9 million 13.9 million

EXAI

Price: $4.97

52 week price:
3.99
9.12

Earnings Per Share: -1.49 USD

P/E Ratio: -4.02

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 445040

Market Capitalization: 626.8 million

Links: